Two meta-analyses that evaluated ACE inhibitors in patients with CHF showed that men benefited more from ACE inhibitor therapy than women [37, 38], with mortality and/or hospitalization reduced by 37% in men vs. 22% in women [37]. The gene discussed is ACE; the disease is congestive heart failure.